Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10176
PUT
Atlanticus Holdings
ATLC
$1.56B
| $190K | ﹤0.01% |
7,000
+1,800
| +35% | +$54.2K |
|
10177
CALL
Kforce
KFRC
$1.04B
| $190K | ﹤0.01% |
3,000
+1,800
| +150% | +$107K |
|
10178
PUT
Astrana Health
ASTH
$2.02B
| $190K | ﹤0.01% |
5,200
-3,700
| -42% | -$130K |
|
10179
CALL
Dragonfly Energy
DFLI
$18.3M
| $190K | ﹤0.01% |
+702
| New | +$386K |
|
10180
CALL
Genpact
G
$5.69B
| $190K | ﹤0.01% |
+4,100
| New | +$191K |
|
10181
PUT
Dream Finders Homes
DFH
$1.42B
| $189K | ﹤0.01% |
14,300
+1,400
| +11% | +$16.5K |
|
10182
PUT
TFS Financial
TFSL
$4.95B
| $189K | ﹤0.01% |
15,000
-1,200
| -7% | -$16.8K |
|
10183
NN Inc
NNBR
$322M
| $189K | ﹤0.01% |
177,001
+137,402
| +347% | +$244K |
|
|
PRPH
10184
DELISTED
ProPhase Labs
PRPH
| $189K | ﹤0.01% |
2,485
+1,396
| +128% | +$113K |
|
10185
CALL
ProShares UltraShort Silver
ZSL
$58M
| $189K | ﹤0.01% |
255
-88
| -26% | -$77K |
|
|
ADAM
10186
CALL
Adamas Trust
ADAM
$910M
| $189K | ﹤0.01% |
19,000
-2,950
| -13% | -$32K |
|
|
PGAL
10187
DELISTED
Global X MSCI Portugal ETF
PGAL
| $189K | ﹤0.01% |
18,021
+1,672
| +10% | +$17.4K |
|
10188
PUT
Capricor Therapeutics
CAPR
$386M
| $189K | ﹤0.01% |
44,800
-39,800
| -47% | -$171K |
|
10189
Natural Gas Services Group
NGS
$490M
| $189K | ﹤0.01% |
18,337
-16,393
| -47% | -$180K |
|
10190
Atlanta Braves Holdings Series B
BATRK
$3.44B
| $189K | ﹤0.01% |
5,609
-44,867
| -89% | -$1.51M |
|
10191
CALL
Douglas Emmett
DEI
$1.96B
| $189K | ﹤0.01% |
15,300
+12,300
| +410% | +$178K |
|
10192
CALL
Avita Medical
RCEL
$243M
| $189K | ﹤0.01% |
13,500
-38,800
| -74% | -$413K |
|
10193
CALL
Grupo Cibest SA
CIB
$22.8B
| $188K | ﹤0.01% |
7,500
+2,100
| +39% | +$56.7K |
|
|
CBAY
10194
PUT
DELISTED
Cymabay Therapeutics
CBAY
| $188K | ﹤0.01% |
21,600
+4,700
| +28% | +$37.6K |
|
10195
CALL
Shenandoah Telecom
SHEN
$735M
| $188K | ﹤0.01% |
9,900
+1,400
| +16% | +$26.2K |
|
10196
Invesco S&P SmallCap Energy ETF
PSCE
$106M
| $188K | ﹤0.01% |
4,061
-5,762
| -59% | -$289K |
|
10197
Spok Holdings
SPOK
$229M
| $188K | ﹤0.01% |
18,556
-21,789
| -54% | -$199K |
|
10198
PUT
State Street SPDR S&P Kensho New Economies Composite ETF
KOMP
$2.85B
| $188K | ﹤0.01% |
4,400
+3,400
| +340% | +$145K |
|
10199
CALL
Eos Energy Enterprises
EOSE
$1.46B
| $188K | ﹤0.01% |
73,100
+10,200
| +16% | +$17.7K |
|
|
MESO
10200
Mesoblast
MESO
$2.02B
| $188K | ﹤0.01% |
28,533
-40,233
| -59% | -$266K |
|
Similar funds
Citadel Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Citadel Advisors held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citadel Advisors withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Citadel Advisors opened a new position in Keurig Dr Pepper worth $238M.
- Citadel Advisors's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Citadel Advisors added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Citadel Advisors's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Citadel Advisors fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Citadel Advisors's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Citadel Advisors opened 1,466 new positions and closed 1,652 in Q1 2023.
- Citadel Advisors's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.